Xponance’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-7,531
Closed -$489K 1327
2023
Q4
$489K Buy
7,531
+26
+0.3% +$1.57K 0.01% 934
2023
Q3
$491K Sell
7,505
-12
-0.2% -$755 0.01% 898
2023
Q2
$437K Sell
7,517
-288
-4% -$18.2K 0.01% 945
2023
Q1
$482K Buy
7,805
+31
+0.4% +$1.86K 0.01% 924
2022
Q4
$494K Sell
7,774
-77
-1% -$5.58K 0.01% 903
2022
Q3
$571K Buy
7,851
+1,862
+31% +$139K 0.01% 791
2022
Q2
$407K Buy
+5,989
New +$430K 0.01% 936

Other funds holding NARI

Xponance's NARI Position: Q1 2024 in Review

Xponance sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2024, closing a stake of 7,531 shares — an estimated $489K sold.

Xponance first reported a position in NARI in Q2 2022 and held it in 7 quarters. The position peaked at $571K in Q3 2022. 231 funds tracked by Wall St. Rank hold NARI as of Q1 2024.

  • Xponance reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Xponance sold 7,531 Inari Medical, Inc. Common Stock shares in Q1 2024, an estimated $489K.
  • Xponance first reported a position in Inari Medical, Inc. Common Stock in Q2 2022 and held it in 7 quarters.
  • Xponance's Inari Medical, Inc. Common Stock position peaked at $571K in Q3 2022.
  • 231 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2024.

Based on Xponance's 13F filing for Q1 2024, filed 13 May 2024.